Article(electronic)June 13, 2012

Early Survival of Comatose Patients after Severe Traumatic Brain Injury with the Dual Cannabinoid CB1/CB2 Receptor Agonist KN38-7271: A Randomized, Double-Blind, Placebo-Controlled Phase II Trial

In: Journal of neurological surgery. Part A, Central European neurosurgery = Zentralblatt für Neurochirurgie, Volume 73, Issue 4, p. 204-216

Firsching, Raimund; Piek, Jürgen; Skalej, Martin; Rohde, Veit; Schmidt, Uwe; Striggow, Frank; the KN38-7271 Study Group

Order using Subito

Checking availability at your location

Languages

English

Publisher

Georg Thieme Verlag KG

ISSN: 2193-6323

DOI

10.1055/s-0032-1304815

ExportReport Issue

Report Issue

If you have problems with the access to a found title, you can use this form to contact us. You can also use this form to write to us if you have noticed any errors in the title display.